Godavari Drugs Ltd. (GODAVARI) 52 Week High Streak: Second Straight Session Near One-Year Peak
- October 12, 2026
- Posted by: Chaitanya Auti
- Category: News
Godavari Drugs Ltd. has now traded within 2% of its 52-week high for its second straight session, with the share price moving 8.52% across the streak. The latest data shows the stock touched Rs 144.35 at the high and was last trading at Rs 140.15, keeping it close to the one-year peak. According to latest Univest data, the repeated pattern is confirmed, but no company-specific catalyst is established for the continued move.
As of 12 October 2026 at 9:52 AM IST, Godavari Drugs Ltd. share price was near Rs 140.15 versus the previous close of Rs 140. The stock opened at Rs 141 and moved between Rs 137.2 and Rs 144.35 during the session. Godavari Drugs Ltd. market cap stood at Rs 152.8 crore. For readers, the key distinction is simple: this is not just a one-day reaction, but a repeated near-high pattern that deserves a broader stock analysis view.
Godavari Drugs Ltd. 52 Week High Streak: Consecutive High Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 140.15 |
| Previous Close | Rs 140 |
| Today's Move | +Rs 0.15 (+0.11%) |
| Open | Rs 141 |
| High | Rs 144.35 |
| Low | Rs 137.2 |
| Market Capitalisation | Rs 152.8 crore |
Godavari Drugs Ltd. (GODAVARI) traded at Rs 140.15 versus the previous close of Rs 140, a rise of 0.11%. The stock opened at Rs 141, reached a high of Rs 144.35 and touched a low of Rs 137.2.
Godavari Drugs Ltd. share price today is showing a narrow move versus the previous close, with the stock last trading at Rs 140.15 after a rise of Rs 0.15, or 0.11%, from Rs 140. The intraday range has been Rs 137.2 to Rs 144.35, which places the stock well within sight of its 52-week high while still trading below the peak. That keeps the current price action relevant for traders scanning 52 week high stocks and for investors following Godavari Drugs Ltd. stock news.
The day opened at Rs 141, which means the stock has spent time above the previous close even as the broader move stayed restrained. Godavari Drugs Ltd. market cap of Rs 152.8 crore places it among smaller listed names in the healthcare space by market value alone, though size does not explain the move. The important point is that the Godavari Drugs Ltd. share price has stayed near its yearly high for a second straight session, which makes the current Godavari Drugs Ltd. stock performance more notable than a single sharp session. That is why searches such as Godavari Drugs Ltd. share price today, Godavari Drugs Ltd. stock news and Stocks At One Year High Today are drawing attention around the counter.
What the Repeated 52-Week Highs Show
Godavari Drugs Ltd. 52 Week High Streak is the real story here: the stock has now remained within 2% of its 52-week high for a second straight session, and the cumulative move across that span is 8.52%. That matters because repeated proximity to a one-year high often draws more attention than a one-off print, even when the market has not confirmed a fresh high for the day.
Latest Univest data confirms the pattern, but it does not identify a company-specific trigger behind Godavari Drugs Ltd. Back To Back 52 Week Highs. In plain terms, the market has kept the stock close to its upper range over two sessions, and that is enough to put it on screens tracking Stocks Hitting 52 Week Highs. The previous event trading date was 9 October 2026, which shows the near-high setup has been active across consecutive sessions rather than appearing only once.
For readers asking why is Godavari Drugs Ltd. still hitting 52 week highs, the correct answer is narrower: the price pattern is confirmed, but the underlying reason is not. That makes this Godavari Drugs Ltd. 52 Week High Streak article different from a one-day breakout note. It focuses on the repeated structure, the cumulative streak move and the fact that the share price has stayed near the one-year high for longer than a single session.
Godavari Drugs Ltd. (GODAVARI) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 152.8 crore |
| P/E Ratio | 36.77x |
| P/B Ratio | 1.94x |
| ROE | 10.64% |
| ROCE | 10.13% |
| EPS | Rs 3.81 |
| Book Value Per Share | Rs 72.07 |
| Dividend Yield | 0% |
Godavari Drugs Ltd. (GODAVARI) fundamental metrics show P/E 36.77x, P/B 1.94x, ROE 10.64%, ROCE 10.13%. These figures provide context only and are not a buy or sell signal.
Godavari Drugs Ltd. has a market capitalisation of Rs 152.8 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 36.77x, P/B at 1.94x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 10.64% and ROCE of 10.13%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 3.81, book value per share of Rs 72.07, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 27.01x, median ROE of 11.22%, median ROCE of 13.1%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 36.77x |
| Benchmark Median P/E | 27.01x |
| Benchmark Average P/E | 39.05x |
| Benchmark P/E Range | 0x to 679.32x |
| Company P/B Ratio | 1.94x |
| Benchmark Median P/B | 2.8x |
| Company ROE | 10.64% |
| Benchmark Median ROE | 11.22% |
| Company ROCE | 10.13% |
| Benchmark Median ROCE | 13.1% |
| Company Market Capitalisation | Rs 152.8 crore |
| Benchmark Median Market Cap | Rs 734.46 crore |
Godavari Drugs Ltd. (GODAVARI) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Godavari Drugs Ltd. (GODAVARI) has a P/E ratio of 36.77x, which is above the benchmark median of 27.01x, a difference of +36.13%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Godavari Drugs Ltd. (GODAVARI) has a ROE of 10.64%, which is below the benchmark median of 11.22%, a difference of -5.17%. Godavari Drugs Ltd. (GODAVARI) has a ROCE of 10.13%, which is below the benchmark median of 13.1%, a difference of -22.67%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Bal Pharma Ltd. | BALPHARMA | 148.3 | 20.57 | 1.78 | 7.92 | 9.78 |
| Auro Laboratories Ltd. | AUROLAB | 147.46 | 31.5 | 3.11 | 7.91 | 9.17 |
| Kimia Biosciences Ltd. | KIMIABL | 161.34 | 22.45 | 8.93 | 186.7 | 42.18 |
| Par Drugs And Chemicals Ltd. | PAR | 144.09 | 9.94 | 1.23 | 14.47 | 19.51 |
| CURIS LIFESCIENCES LTD | CURIS | 163.31 | 23.61 | 3.45 | 55.25 | 34.25 |
Godavari Drugs Ltd. (GODAVARI) has a P/E ratio of 36.77x compared with the displayed peer median of 22.45x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 10.64% compares with a peer median of 14.47% across the companies shown in the table. ROCE stood at 10.13% versus the displayed peer median of 19.51%, providing a capital-efficiency comparison. Godavari Drugs Ltd. (GODAVARI) has a market capitalisation of Rs 152.8 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Godavari Drugs Ltd.
- Godavari Drugs Ltd. 52 Week High Streak has extended into a second straight session, keeping the stock near its one-year high.
- The cumulative streak move is 8.52%, which gives the repeated-high pattern more context than a single-day print.
- Godavari Drugs Ltd. share price today remains close to the upper end of the day’s Rs 137.2 to Rs 144.35 range.
- The stock trades at a P/E of 36.77 and P/B of 1.94, so Godavari Drugs Ltd. Fundamental Analysis remains relevant.
- Healthcare sector and peer comparison data show the move should be assessed against industry valuation norms, not price alone.
About Godavari Drugs Ltd.
Godavari Drugs Ltd. is a listed company in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company’s market capitalisation stands at Rs 152.8 crore, and its share price is being tracked closely because it continues to trade near its 52-week high. Godavari Drugs Ltd. stock news around the counter is therefore attracting attention from readers watching Stocks Hitting 52 Week Highs and Godavari Drugs Ltd. Stock Performance.
The latest financial ratios place Godavari Drugs Ltd. at a P/E of 36.77, P/B of 1.94, ROE of 10.64% and ROCE of 10.13%. EPS is Rs 3.81 and book value is Rs 72.07. Those figures provide a basic framework for Godavari Drugs Ltd. share price update analysis, especially when the market is already keeping the stock close to a one-year peak.
For investors, the main question is not whether the share price has moved, but whether the streak can be understood through business and valuation context. That is why Godavari Drugs Ltd. 52 Week High Streak is worth tracking alongside financial ratios and sector context rather than as a standalone price headline.
The article reflects market data observed as of 12 October 2026 at 9:52 AM IST and is intended for information and research purposes only.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
What does Godavari Drugs Ltd. 52 Week High Streak mean?
Ans. It means Godavari Drugs Ltd. has traded within 2% of its 52-week high for consecutive sessions. In this case, the stock is in its second straight session near the one-year peak, with an 8.52% move across the streak.
Has Godavari Drugs Ltd. made a new 52-week high today?
Ans. No. The latest reading shows Godavari Drugs Ltd. trading near its 52-week high, but not necessarily breaking it. The relevant event is proximity to the yearly high across consecutive sessions, not a fresh record print.
What is the current Godavari Drugs Ltd. share price today?
Ans. Godavari Drugs Ltd. was last trading at Rs 140.15 as of 12 October 2026 at 9:52 AM IST. The stock was up Rs 0.15, or 0.11%, versus the previous close of Rs 140.
How strong is the repeated near-high move in Godavari Drugs Ltd.?
Ans. The repeated pattern is notable because it has lasted for a second straight session and covers an 8.52% move across the streak. That keeps Godavari Drugs Ltd. on lists of Stocks Hitting 52 Week Highs.
Is there a confirmed catalyst behind the Godavari Drugs Ltd. move?
Ans. No company-specific catalyst is confirmed by the latest Univest figures. The data confirms the price pattern near the 52-week high, but it does not identify a reason for the continued move.
How does Godavari Drugs Ltd. look on valuation?
Ans. Godavari Drugs Ltd. trades at a P/E of 36.77 and a P/B of 1.94. Against the same-industry median, it is richer on earnings and below the median on book value, so the valuation picture is mixed.
What do the fundamentals suggest for Godavari Drugs Ltd.?
Ans. ROE is 10.64% and ROCE is 10.13%, with EPS at Rs 3.81 and book value at Rs 72.07. The numbers show a steady operating profile, but not one that clearly dominates its peer set.
Why are investors tracking Godavari Drugs Ltd. stock performance now?
Ans. Investors are watching because the stock remains close to its yearly high for back-to-back sessions. That pattern, plus the sector and peer comparison, makes Godavari Drugs Ltd. Stock Performance relevant for near-term monitoring.
Track Godavari Drugs Ltd. (GODAVARI) Share Price on Univest
Use Godavari Drugs Ltd. (GODAVARI) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.